Patents
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
07/2001
07/17/2001US6261776 Nucleic acid arrays
07/12/2001WO2001049275A2 Methods and compositions for mitigating pain using nitrate esters
07/12/2001CA2394184A1 Methods and compositions for mitigating pain using nitrate esters
07/11/2001EP1114022A1 Process for producing stereoselective nitro compounds
07/10/2001US6258962 Reacting alkylene oxide with carbon dioxide
07/10/2001US6258843 4-oxy-3-(aryl)phenyl-arylcarbonyloxy compounds useful as phosphodiesterase inhibitors
07/05/2001WO2001047899A1 Substituted piperazine derivatives as mtp inhibitors
07/05/2001WO2001047862A1 Optically active materials
07/05/2001US20010006962 Behavior of biologically active compounds favorably modified by replacing a functional group with an unsaturated fatty derivative, e.g. elaidic acid; bioavailability; membrane passage; organ targeting; drugs; agriculture
07/05/2001DE19963235A1 Substituierte Piperazinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel Substituted piperazine derivatives, their preparation and their use as medicaments
07/05/2001CA2394644A1 Substituted piperazine derivatives,the preparation thereof and their useas medicaments
07/04/2001EP1112250A1 Therapeutic compounds and methods
07/04/2001EP1112240A1 The addition of oxygen nucleophiles to vinyl epoxides
07/03/2001US6255528 Reacting an alkylfluorobromobenzene or fluorobromobenzene with acrylamide in presence of palladium catalyst, hydrogenating the resulting arylacrylamide, and then rearranging it
07/03/2001US6255496 Trifluoromethyl ketone analogs as selective cPLA2 inhibitors
06/2001
06/28/2001WO2001046125A2 Cd45 inhibitors
06/28/2001WO2001045709A1 Substituted piperazine and piperidine calcium channel blockers
06/28/2001WO2001010834A3 Antibacterial agents
06/28/2001WO2000003981A8 Preparation of (s)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes
06/28/2001DE19960204A1 Substituierte Norlbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament Norlbornylamino substituted derivatives, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing
06/28/2001DE10063410A1 New optically active dioxabicyclo-octen-2-one derivatives, useful as intermediates, e.g. for prostaglandins, and their intermediates
06/27/2001EP1110961A1 Oxygenic heterocyclic compounds
06/27/2001EP1110943A1 6-fluorobicyclo 3. 1.0]hexane derivatives
06/27/2001CN1301259A & alpha; -(1-piperazinyl) ocetamido arenecarboxylic acid derivatives as antidiabetic agents
06/26/2001US6252092 Process for synthesis of 5-alkylbenzodioxoles
06/26/2001US6251937 5,6-0-alkylidene glucono-1(4)-lactones and derivatives, processes for their preparation and uses thereof
06/21/2001WO2001044225A1 Dinitrile intermediates for the synthesis of omapatrilat and methods for producing same
06/21/2001WO2001044202A1 Hydantoin intermediates for the synthesis of omapatrilat and methods for producing and using the same
06/21/2001WO2001044172A1 Salicylamides as serine protease and factor xa inhibitors
06/21/2001WO2001044164A1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds
06/21/2001US20010004457 Prepared by acetalating acetaldehyde at a temperature of 20 degrees C. or below with racemic or enantiomerically pure 1-phenyl-1,2-ethanediol; perfumes
06/21/2001DE19961431A1 2-Methyl-4-phenyl-1,3-dioxolan 2-methyl-4-phenyl-1,3-dioxolane
06/21/2001DE10061948A1 Lichtempfindliche Harzzusammensetzung A photosensitive resin composition
06/21/2001CA2394639A1 Salicylamides as serine protease and factor xa inhibitors
06/21/2001CA2394130A1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds
06/20/2001EP1108719A2 2-methyl-4-phenyl-1,3-dioxolane
06/20/2001EP1108706A1 Catalytic synthesis of aldehydes by direct hydrogenation of carboxylic acids
06/20/2001EP1107961A1 Inhibition and treatment of hepatitis b virus and flavivirus by helioxanthin and its analogs
06/19/2001US6248882 Via dioxolane intermediates
06/19/2001US6248775 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
06/19/2001US6248743 Antithrombotic agents effective to inhibit the production of type 1 plasminogen activator inhibitor (pai-1)
06/19/2001CA2028048C Derivatives of 1,4-dideoxy-1,4-imino-d-mannitol
06/15/2001CA2328342A1 Photosensitive resin composition
06/14/2001WO2001041778A1 Melanin synthesis inhibition compound and composition containing the same
06/13/2001CN1067050C Method for prodn. of 3-alkoxy-2-substituted phenmethyl acid or ester thereof
06/13/2001CN1067044C Novel tricyclic derivatives, their prepn. process
06/12/2001CA2080917C New pharmacologically active catechol derivatives
06/07/2001WO2001040188A1 Curcumin analogues for treating cancer
06/07/2001WO2001040153A1 PROCESS FOR PREPARING OPTICALLY ACTIVE α-HYDROXY ACIDS AND DERIVATIVES THEREOF
06/07/2001CA2393440A1 Curcumin analogs with anti-tumor and anti-angiogenic properties
06/07/2001CA2390815A1 Process for preparing optically active .alpha.-hydroxy acids and derivatives thereof
06/06/2001EP1104395A1 Stereoselective ring opening reactions
06/06/2001CN1298401A Method for the continuous production of 1,3-dioxolan-2-ones
06/06/2001CN1298400A Novel cyclic pro-perfumes having modifiable fragrance raw material alcohol release rate
06/06/2001CN1298399A Substituted alxoxycarbonyl compounds
06/05/2001US6242644 N-(4-carbamimidoyl-phenyl)-glycine derivatives
06/05/2001US6242494 Angiogenesis inhibitors, antitumor agents, diabetic retinopathy, and antiinflammatory agents
06/05/2001US6242438 3-Azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
05/2001
05/31/2001WO2001038319A1 Dioxolone and its use as electrolytes
05/31/2001WO2001037826A1 Npyy5 antagonists
05/31/2001DE19956363A1 New 2,2-di(fluoro)alkyl- and 2,2-di(fluoro)alkyl-5-mono- and -5,5-di(halo)alkyl-1,3-dioxol-4-ones containing halogen and known analogs are used as solvent, e.g. in battery
05/30/2001EP1102744A1 Novel method for preparing optically active alpha-aminonitriles
05/30/2001EP1102743A1 Amide derivatives which are useful as cytokine inhibitors
05/30/2001EP1102742A2 Compounds and compositions for delivering active agents
05/29/2001US6239176 Administering to treat blood disorders like anemia; wound healing, anticarcinogenic and antiproliferative agents; genetic disorders
05/29/2001US6239175 Carbamoyloxy derivatives of mutiline and their use as antibacterials
05/29/2001US6239074 Substituted 3-phenyluracils
05/29/2001CA2027016C Process for preparing 2,2-difluoro-1,3-benzodioxole
05/25/2001WO2001036403A1 Urea derivatives as anti-inflammatory agents
05/25/2001WO2000077027A3 Serine protease inhibitors
05/25/2001WO2000039081A3 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
05/24/2001US20010001799 Anticoagulant
05/23/2001EP1101762A1 Process for preparation of vinylene carbonate and its use
05/23/2001EP1100774A1 Improved arylamine synthesis
05/23/2001EP1100772A1 Open chain alkoxyamine compounds and their use as polymerization regulators
05/23/2001EP1100769A1 Aminomethylcarboxylic acid derivatives
05/23/2001EP0851864B1 Novel coupling agents, processes for their preparation and hair dyes
05/23/2001CN1296471A Substituted 2-phenyl-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system and pharmaceutical compositions containing them
05/22/2001US6235927 Process for the separation of a mixture of enantiomers
05/22/2001US6235903 Method for preparing sulfanyl-type endothelin receptor antagonists
05/22/2001US6235787 Antiinflammatory agents; rheumatic diseases; bone disorders; skin disorders; multiple sclerosis
05/22/2001US6235778 Anticoagulants
05/22/2001US6235753 Tumor necrosis factor; autoimmune diseases; antiallergens
05/22/2001US6235732 Neurokinin antagonists
05/19/2001CA2326297A1 Process for the prepartion of vinylene carbonate and the use thereof
05/16/2001EP1099692A1 N,n-substituted cyclic amine derivatives
05/16/2001EP0882719B1 Arylethenesulfonamide derivatives and drug composition containing the same
05/16/2001EP0695300B1 Novel 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents
05/16/2001CN1295562A Biocidal benzylbiphenyl derivatives
05/15/2001US6232476 Intermediates in a process for cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]ethyl}pyrrolidine
05/15/2001US6232475 Reacting a substituted bromobenzene with n-vinylimide; catalytic hydrogenation
05/15/2001US6232314 Arylalkylpiperazine compounds as antioxidants
05/10/2001WO2001032654A2 Novel heterocyclic compounds and their use as medicines
05/10/2001WO2001032609A1 Novel compounds having cyano and insecticides and miticides
05/10/2001WO2001032602A1 Diaryl-enynes
05/10/2001WO2001004122A3 New 2,3-benzodiazepine derivatives
05/10/2001CA2387660A1 Diaryl-enynes as glycine transport inhibitors
05/09/2001EP1097925A1 Novel benzoic acid derivatives and processes for the preparation thereof
05/09/2001EP1097158A2 Ligands for metals and metal-catalyzed processes
05/09/2001EP1097149A1 Bicyclohexane derivatives